Live Breaking News & Updates on Institutional Trading Of Longboard Pharmaceuticals

Stay updated with breaking news from Institutional trading of longboard pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Longboard Pharmaceuticals (NASDAQ:LBPH) Earns "Overweight" Rating from Cantor Fitzgerald

Longboard Pharmaceuticals (NASDAQ:LBPH) Earns "Overweight" Rating from Cantor Fitzgerald
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Insider Transactions At Longboard Pharmaceuticals , Manufacturers Life Insurance Company , Arena Pharmaceuticals Inc , Institutional Trading Of Longboard Pharmaceuticals , Analyst Recommendations For Longboard Pharmaceuticals , Longboard Pharmaceuticals Company Profile , Longboard Pharmaceuticals , Longboard Pharmaceuticals Trading Down , Nuveen Asset Management , Citigroup Inc , News Ratings For Longboard Pharmaceuticals Daily , Longboard Pharmaceuticals Inc , Cantor Fitzgerald , Northern Trust Corp , Goldman Sachs Group Inc , Securities Exchange Commission , Free Report , Pharmaceuticals Trading Down , Get Free Report , Exchange Commission , Asset Management , Sachs Group , Trust Corp , Longboard Pharmaceuticals Daily ,

Longboard Pharmaceuticals (NASDAQ:LBPH) Earns Buy Rating from Analysts at Citigroup

Citigroup began coverage on shares of Longboard Pharmaceuticals (NASDAQ:LBPH – Free Report) in a research report sent to investors on Friday, Marketbeat reports. The firm issued a buy rating and a $40.00 price target on the stock. Several other equities analysts have also recently weighed in on the company. Cantor Fitzgerald raised their price objective […] ....

United States , Longboard Pharmaceuticals Stock , American International Group Inc , Longboard Pharmaceuticals Inc , Arena Pharmaceuticals Inc , Institutional Trading Of Longboard Pharmaceuticals , News Ratings For Longboard Pharmaceuticals Daily , Cantor Fitzgerald , Bourgeon Capital Management , Analyst Recommendations For Longboard Pharmaceuticals , York Mellon Corp , Securities Exchange Commission , Longboard Pharmaceuticals , Longboard Pharmaceuticals Company Profile , Td Asset Management Inc , Free Report , Exchange Commission , Management Inc , Montreal Can , International Group , Capital Management , New York Mellon Corp , Get Free Report , Longboard Pharmaceuticals Daily , Nasdaq Lbph , Initiated Coverage ,

Longboard Pharmaceuticals (NASDAQ:LBPH) Trading Down 6.6%

Longboard Pharmaceuticals (NASDAQ:LBPH) Trading Down 6.6%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Nova Scotia , United States , News Ratings For Longboard Pharmaceuticals Daily , Cantor Fitzgerald , Longboard Pharmaceuticals , Blackrock Inc , Longboard Pharmaceuticals Inc , Institutional Trading Of Longboard Pharmaceuticals , Bourgeon Capital Management , Td Asset Management Inc , Longboard Pharmaceuticals Trading , Longboard Pharmaceuticals Company Profile , American International Group Inc , Get Free Report , Montreal Can , International Group , Management Inc , Capital Management , Longboard Pharmaceuticals Daily ,

Cantor Fitzgerald Boosts Longboard Pharmaceuticals (NASDAQ:LBPH) Price Target to $60.00

Cantor Fitzgerald Boosts Longboard Pharmaceuticals (NASDAQ:LBPH) Price Target to $60.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Wells Fargo Company , Northern Trust Corp , Manufacturers Life Insurance Company , Institutional Trading Of Longboard Pharmaceuticals , Longboard Pharmaceuticals Inc , Cantor Fitzgerald , Longboard Pharmaceuticals , Analyst Recommendations For Longboard Pharmaceuticals , Citigroup Inc , News Ratings For Longboard Pharmaceuticals Daily , Longboard Pharmaceuticals Trading , Get Free Report , Trust Corp , State Teachers Retirement System , Wells Fargo , Longboard Pharmaceuticals Daily ,

Cantor Fitzgerald Reiterates Overweight Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)

Cantor Fitzgerald reissued their overweight rating on shares of Longboard Pharmaceuticals (NASDAQ:LBPH – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. The firm currently has a $35.00 price objective on the stock, up from their previous price objective of $16.00. Cantor Fitzgerald also issued estimates for Longboard Pharmaceuticals’ FY2023 […] ....

United States , Longboard Pharmaceuticals Stock Down , Citigroup Inc , Analyst Recommendations For Longboard Pharmaceuticals , American International Group Inc , Metlife Investment Management , Cantor Fitzgerald , Longboard Pharmaceuticals Inc , Institutional Trading Of Longboard Pharmaceuticals , Longboard Pharmaceuticals , Wells Fargo Company , News Ratings For Longboard Pharmaceuticals Daily , Free Report , Longboard Pharmaceutical , Pharmaceuticals Stock Down , Get Free Report , State Teachers Retirement System , International Group , Longboard Pharmaceuticals Daily , Nasdaq Lbph , Reiterated Rating ,